These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 90860)

  • 1. Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.
    Long RG; Barnes AJ; Adrian TE; Mallinson CN; Brown MR; Vale W; Rivier JE; Christofides ND; Bloom SR
    Lancet; 1979 Oct; 2(8146):764-7. PubMed ID: 90860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin and diabetes.
    Gerich JE
    Am J Med; 1981 Mar; 70(3):619-26. PubMed ID: 6111219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
    Wood SM; Kraenzlin ME; Adrian TE; Bloom SR
    Gut; 1985 May; 26(5):438-44. PubMed ID: 2860052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic somatostatinoma. Clinical features and physiological implications.
    Larsson LI; Hirsch MA; Holst JJ; Ingemansson S; Kühl C; Jensen SL; Lundqvist G; Rehfeld JF; Schwartz TW
    Lancet; 1977 Mar; 1(8013):666-8. PubMed ID: 66472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
    Tomita T
    Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man.
    Barnes AJ; Long RG; Adrian TE; Vale W; Brown MR; Rivier JE; Hanley J; Ghatei MA; Sarson DL; Bloom SR
    Clin Sci (Lond); 1981 Nov; 61(5):653-6. PubMed ID: 6116553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects.
    Kraenzlin ME; Wood SM; Neufeld M; Adrian TE; Bloom SR
    Experientia; 1985 Jun; 41(6):738-40. PubMed ID: 2861106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995.
    Kung AW; Ma JT; Wang C; Fu KH; Lam KS; Yeung RT; Boey J
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):469-73. PubMed ID: 2893673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995.
    Anderson JV; Bloom SR
    Scand J Gastroenterol Suppl; 1986; 119():115-28. PubMed ID: 2876495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed endocrine pancreatic tumors producing several peptide hormones.
    Larsson LI; Grimelius L; Håkanson R; Rehfeld JF; Stadil F; Holst J; Angervall L; Sundler F
    Am J Pathol; 1975 May; 79(2):271-84. PubMed ID: 167586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
    Chideckel EW; Palmer J; Koerker DJ; Ensinck J; Davidson MB; Goodner CJ
    J Clin Invest; 1975 Apr; 55(4):754-62. PubMed ID: 804491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone-producing tumours of the pancreas.
    Giddings AE
    Practitioner; 1975 Jun; 214(1284):795-800. PubMed ID: 167363
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
    Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I
    Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets.
    Hellman B; Salehi A; Gylfe E; Dansk H; Grapengiesser E
    Endocrinology; 2009 Dec; 150(12):5334-40. PubMed ID: 19819962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional subdivision of islets of Langerhans and possible role of D cells.
    Orci L; Unger RH
    Lancet; 1975 Dec; 2(7947):1243-4. PubMed ID: 53729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin content of pancreatic endocrine tumors.
    Bloom SR; Polak JM; West AM
    Metabolism; 1978 Sep; 27(9 Suppl 1):1235-8. PubMed ID: 210353
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.